Acute and chronic prostatitis

Medical Clinics of North America

Volumn 88, Issue 2, 2004, Pages 483-494

  Hua, Vi N ^a   Schaeffer, Anthony J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABSCESS DRAINAGE; ACUTE BACTERIAL PROSTATITIS; ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; CHRONIC PROSTATITIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE CLASSIFICATION; ENTEROBACTER; ESCHERICHIA COLI; FEEDBACK SYSTEM; HEALTH CARE ORGANIZATION; HUMAN; HYDRATION; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PELVIS FLOOR; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSTATE SECRETION; PROSTATITIS; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; REVIEW; SERRATIA MARCESCENS; STONE FORMATION; TRANSURETHRAL RESECTION; URINE CULTURE;

EID: 1242269769     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(03)00169-X     Document Type: Review

References (49)

1. Krieger J.N., Ross S.O., Riley D.E. Chronic prostatitis: epidemiology and role of infection. [discussion] Urology. 60:2002;8-13.
2. Campbell M.F. Principles of urology: an introductory text to the diseases of the urogenital tract. 1957;WB Saunders, Philadelphia.
3. Meares E.M., Stamey T.A. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 5:1968;492-518.
4. Drach G.W., Fair W.R., Meares E.M.J., et al. Classification of benign disease associated with prostatic pain: prostatitis or prostatodynia? J Urol. 120:1978;266.
5. Meares E.M. Jr. Prostatitis. Med Clin North Am. 75:1991;405-424.
6. Schaeffer A.J., Wendel E.F., Dunn J.K., et al. Prevalence and significance of prostatic inflammation. J Urol. 125:1981;215-219.
7. Krieger J.N., Nyberg L. Jr., Nickel J.C. NIH consensus definition and classification of prostatitis. JAMA. 282:1999;236-237.
8. Krieger J.N., Egan K.J., Ross S.O., et al. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis" [discussion] Urology. 48:1996;715-722.
9. Stamm W.E. Measurement of pyuria and its relation to bacteriuria. Am J Med. 75:1983;53-58.
10. Schaeffer A.J. Classification (traditional and National Institutes of Health) and demographics of prostatitis. [discussion] Urology. 60:2002;5-7.
11. Nickel J.C., Downey J., Johnston B., et al., Group T.C. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol. 165:2001;1539-1544.
12. Schaeffer A.J., Landis J.R., Knauss J.S., et al. Demographic and clinical characteristics of men with chronic prostatitis: the NIH Chronic Prostatitis Cohort Study. J Urol. 168:2002;593-598.
13. Shoskes D.A., Hakim L., Ghoniem G., et al. Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol. 169:2003;1406-1410.
14. Terai A., Ishitoya S., Mitsumori K., et al. Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis. J Urol. 164:2000;1945-1947.
15. Schaeffer A.J. Diagnosis and treatment of prostatic infections. Urology. 36:1990;13-17.
16. Fowler J.E. Jr. Antimicrobial therapy for bacterial and nonbacterial prostatitis. [discussion] Urology. 60:2002;24-26.
17. Meares E.M. Jr. Prostatic abscess. J Urol. 136:1986;1281-1282.
18. Leport C., Rousseau F., Perronne C., et al. Bacterial prostatitis in patients infected with the human immunodeficiency virus. J Urol. 141:1989;334-336.
19. Weidner W., Schiefer H.G., Krauss H., et al. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection. 19:1991;S119-S125.
20. Doble A. Chronic prostatitis. Br J Urol. 74:1994;537-541.
21. Aagaard J., Madsen P.O. Bacterial prostatitis: new methods of treatment. Urology. 37:1991;4-8.
22. Schaeffer A.J., Darras F.S. The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. J Urol. 144:1990;690-693.
23. Weidner W., Schiefer H.G., Brahler E. Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol. 146:1991;350-352.
24. Yamamoto M., Hibi H., Satoshi K., et al. Chronic bacterial prostatitis treated with intraprostatic injection of antibiotics. Scand J Urol Nephrol. 30:1996;199-202.
25. Meares E.M. Jr. Prostatitis syndromes: new perspectives about old woes. J Urol. 123:1980;141-147.
26. McNeal J.E. Regional morphology and pathology of the prostate. Am J Clin Pathol. 49:1968;347-357.
27. Pewitt E.B., Schaeffer A.J. Urinary tract infection in urology, including acute and chronic prostatitis. Infect Dis Clin North Am. 11:1997;623-646.
28. Litwin M.S., McNaughton-Collins M., Fowler F.J. Jr., et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 162:1999;369-375.
29. Turner J.A., Ciol M.A., Von Korff M., Berger R. Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. J Urol. 169:2003;580-583.
30. Litwin M.S. A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index. [discussion] Urology. 60:2002;14-19.
31. Nickel J.C. Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome. [discussion] Urology. 60:2002;20-23.
32. Krieger J.N., Jacobs R.R., Ross S.O. Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia? J Urol. 164:2000;1554-1558.
33. Schaeffer A.J., Knauss J.S., Landis J.R., et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol. 168:2002;1048-1053.
34. Lee J.C., Muller C.H., Rothman I., et al. Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. [discussion] J Urol. 169:2003;584-588.
35. Krieger J.N., Riley D.E. Bacteria in the chronic prostatitis-chronic pelvic pain syndrome: molecular approaches to critical research questions. J Urol. 167:2002;2574-2583.
36. Schaeffer A.J., Datta N.S., Fowler J.E. Jr., et al. Overview summary statement: diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology. 60:2002;1-4.
37. Cheah P.Y., Liong M.L., Yuen K.H., et al. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol. 169:2003;592-596.
38. Barbalias G.A., Nikiforidis G., Liatsikos E.N. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol. 159:1998;883-887.
39. Nickel J.C., Pontari M., Moon T., et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol. 169:2003;1401-1405.
40. Clemens J.Q., Nadler R.B., Schaeffer A.J., et al. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology. 56:2000;951-955.
41. Nadler R.B. Bladder training biofeedback and pelvic floor myalgia. [discussion] Urology. 60:2002;42-44.
42. Carver B.S., Bozeman C.B., Williams B.J., Venable D.D. The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol. 169:2003;589-591.
43. Nickel J.C., Downey J., Young I., Boag S. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int. 84:1999;976-981.
44. Nadler R.B., Humphrey P.A., Smith D.S., Catalona W.J., Ratliff T.L. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 154:1995;407-413.
45. Bozeman C.B., Carver B.S., Eastham J.A., Venable D.D. Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol. 167:2002;1723-1726.
46. Potts J.M. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol. 164:2000;1550-1553.
47. Gerstenbluth R.E., Seftel A.D., MacLennan G.T., et al. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation. J Urol. 167:2002;2267-2270.
48. Nadler R.B., Koch A.E., Calhoun E.A., et al. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 164:2000;214-218.
49. Jank T.L., Schaeffer A.J. The role of cytokines in prostatitis. World J Urol. 21:(2):2003;95-99.